Dicolano, Norbea M.

HRN: 23-15-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2026
CEFUROXIME 750MG (VIAL)
04/02/2026
04/09/2026
IV
750mg
Q8
Pcap C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines